language_icon
EN
HI

GPT Healthcare Share price

GPTHEALTH

139.99

0.66 (-0.47%)
NSE
BSE
Last updated on 22 May, 2026 | 15:30 IST
Today's High

141.54

Today's Low

138.52

52 Week Low

115.00

52 Week High

185.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

GPT Healthcare Chart

GPT Healthcare Share Key Metrics

Volume
66112.00
Market Cap
1148.69 CR
LTQ@LTP
226@139.99
ATP
139.97
Var Margin
15.32 %
Circuit Range
112.52-168.78
Delivery %
56.59 %
Value
92.54 L
ASM/GSM
No
Market Lot
1

Summary

GPT Healthcare share price is ₹139.99 as of 23 May, 2026. The stock GPT Healthcare intraday movement has stayed between ₹138.52 and ₹141.54, while on a 52-week basis,GPT Healthcare price 52 week high is ₹185.00 & its 52 week low is ₹115.00.
In terms of trading activity, GPT Healthcare has recorded a volume of 66112 shares, The GPT Healthcare has a market cap of ₹82054823 CR. The stock’s Average Traded Price (ATP) stands at ₹139.97, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 226 @ ₹139.99.
GPT Healthcare operates within a circuit range of ₹112.52 – ₹168.78, with a Value of ₹92.54 L. The Delivery Percentage for the day is 56.59%. Additionally, GPT Healthcare currently falls under the No framework, and trades with a market lot size of 1.

GPT Healthcare Fundamentals

View More
P/E Ratio

27.65

P/B Ratio

0

Div. Yield

1.78

Sector P/E

57.12

Sector P/B

-15.74

Sec. Div. Yield

0.19

GPT Healthcare Resistance and Support

Pivot 141.33

Resistance

First Resistance

142.66

Second Resistance

144.68

Third Resistance

146.01

Support

First Support

139.31

Second Support

137.98

Third Support

135.96

GPT Healthcare Shareholding Pattern

View More
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

65.57%

Mutual Fund

4.69%

Insurance

0.01%

Foreign Institutional Investors

2.81%

Domestic Institutional Investors

0.93%

Retail

25.98%

Others

0.01%

Total Promoters
MAR '26
65.57%

GPT Healthcare Corporate Actions

DateAgenda
2026-05-18Audited Results & Final Dividend
2026-02-02Quarterly Results
2025-11-08Quarterly Results & Interim Dividend
2025-08-06Quarterly Results
2025-05-23Audited Results & Final Dividend
2025-02-11Quarterly Results

GPT Healthcare News

GPT Healthcare Limited

GPT HEALTHCARE LTD's Board recommended a final dividend of Rs.1.50 per equity share for FY26. The record date for the dividend is July 30, 2026, with payment expected by September 4, 2026, after shareholder approval at the AGM.
May 18 2026 20:05:00

GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

GPT Healthcare announced Q4 FY26 results with revenue growing 24.3% YoY to Rs.128.0 cr and net profit increasing 13.0% YoY to Rs.14.7 cr. For the full fiscal year FY26, revenue increased by 15.14% to Rs.478.5 cr.
May 18 2026 18:05:00

GPT Healthcare Limited

GPT Healthcare's Board has approved the convening of its 37th Annual General Meeting on August 6, 2026. Additionally, the Board recommended a final dividend of Rs.1.50 per equity share for the financial year 2025-26, setting July 30, 2026, as the record date.
May 18 2026 18:05:00

GPT Healthcare Limited

GPT Healthcare's Board has approved the convening of its 37th Annual General Meeting on August 6, 2026. Additionally, the Board recommended a final dividend of Rs.1.50 per equity share for the financial year 2025-26, setting July 30, 2026, as the record date.
May 18 2026 18:05:00

GPT Healthcare Ltd - 544131 - Corporate Action-Board approves Dividend

GPT Healthcare's board recommended a final dividend of ₹1.50 per equity share for FY26. The dividend, representing 15% of face value, is subject to shareholder approval at the upcoming AGM.
May 18 2026 18:05:00

GPT Healthcare Ltd - 544131 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 18, 2026

GPT Healthcare's Board approved FY26 audited financial results: total income ₹478.49 crore (up 15.14% YoY) and net profit ₹42.22 crore (down 15.42% YoY). A final dividend of ₹1.50 per equity share was recommended for FY26. The 37th AGM to approve the dividend is scheduled for August 6, 2026.
May 18 2026 17:05:00

GPT Healthcare Ltd - 544131 - Board Meeting Intimation for Approval Of Audited Results And Recommendation Of Final Dividend, If Any.

GPT Healthcare's Board of Directors is scheduled to meet on May 18, 2026. The agenda includes considering the audited financial results for the fourth quarter and full financial year ended March 31, 2026, and recommending a final dividend for FY26.
May 11 2026 15:05:00
Read More

About GPT Healthcare

NSE : 22846  
BSE : 544131  
ISIN : INE486R01017  

Our Company was originally incorporated as “Jibansatya Printing House Private Limited” a private limited company under the Companies Act 1956 on August 17 1989 at Kolkata West Bengal. The name of our Company was subsequently changed to “GPT Healthcare Private Limited” so that the name of the Company is in consonance with the main objects of the Memorandum of Association in relation to the proposed business activities to be carried out by the Company. A fresh certificate of incorporation was issued by the RoC on March 31 2005. Thereafter pursuant to a special resolution passed by our shareholders on September 3 2021 our Company was converted to a public limited company and our name was changed to “GPT Healthcare Limited”. A fresh certificate of incorporation consequent to change of name was issued by the RoC on September 15 2021.Major events and milestones:1989Incorporation of our Company2000Company started the hospital business in Salt Lake West Bengal2005Tantia Medical Services Private Limited sold its nursing home business to the Company on a going concern basis2008Company signed lease agreement for our multi-specialty Agartala Hospital2011Commissioned our Agartala Hospital with a capacity of 205 beds with a Nursing School2013Commissioned our Dum Dum Hospital2016Our Dum Dum Hospital received permission to provide kidney transplantation service2019Commissioned our Howrah Hospital2021-Initiated B.Sc Nursing Programme with an intake capacity of 45 students in our Agartala Hospital-Signed a lease agreement for a new hospital in Ranchi on September 17 20212023-Signed a memorandum of understanding for the construction and finishing of a hospital building at Raipur on January 16 2023-Signed a cancer care department management agreement to set up and operate the cancer care department at our Agartala Hospital on September 1 2023

Read More

GPT Healthcare Management

NamePosition
Ankur SharmaCompany Secretary & Compliance Officer
Om TantiaChairman & Managing Director
View More

GPT Healthcare FAQs

The Buying Price of GPT Healthcare share is 139.99 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy GPT Healthcare stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for GPT Healthcare, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of GPT Healthcare shares is 27.65. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio GPT Healthcare shares is 0. Useful to assess the stock's value relative to its book value.

To assess GPT Healthcare’s valuation compare Sector P/E, P/B which are 57.12 & -15.74 with sector averages, along with growth rates and financial metrics.

The Market Cap of GPT Healthcare is 1148.69 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of GPT Healthcare share price is 185.00 & 115.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

GPT Healthcare belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost